Electroacupuncture for Recovery After Colorectal Cancer Surgery
Study Overview
This study, called the CORRECT trial, investigates how electroacupuncture (EA) can help patients recover from gastrointestinal issues after colorectal cancer surgery. Postoperative gastrointestinal dysfunction (POGD) is common and needs effective treatment options.
Study Details
The CORRECT trial will involve:
- 300 participants with colorectal cancer undergoing surgery.
- Participants will be divided into three groups: EA group, sham-electroacupuncture group, and control group.
- All groups will follow a standardized recovery protocol.
- The EA group will receive treatment at specific acupuncture points twice daily for four days after surgery.
Goals of the Study
The main goal is to measure:
- Time to first flatus (passing gas).
- Time to first defecation (bowel movement).
- Other factors like nausea, pain levels, and hospital stay duration.
Importance of the Trial
The CORRECT trial aims to provide strong evidence on the effectiveness of EA for POGD. The findings could help integrate acupuncture into recovery plans, allowing for personalized treatment based on patient needs.
Trial Registration
The trial is registered on ClinicalTrials.gov with the identifier: NCT06128785. For more details, visit ClinicalTrials.gov.
Enhancing Clinical Practice
Clinical trials are essential for developing safe treatments. Our AI-driven platform, DocSym, helps clinicians access vital information easily, improving patient care.
Streamlining Healthcare
Our mobile apps assist with scheduling, monitoring treatments, and telemedicine, making patient management simpler and more efficient.
Improving Outcomes with AI
By using AI, clinics can enhance workflows, improve patient outcomes, and reduce paperwork. Learn more at aidevmd.com.
